EdiShorts

India’s Stakes in the WHO Pandemic Agreement: The Unfinished Pathogen Access and Benefit-Sharing Annex

IssueOctober 2026
PaperGS Paper 2
SubjectInternational Relations
Read time4 min

Why in News: The WHO Pandemic Agreement, adopted by the World Health Assembly in May 2025, still cannot open for signature because member States have not finalised its Pathogen Access and Benefit-Sharing (PABS) annex. The May 2026 deadline was missed; negotiations were extended to the World Health Assembly of May 2027 (or an earlier special session). At the UN High-Level Meeting on pandemic preparedness on 25 September 2026, India said the political declaration should not prejudge the PABS talks and stressed equitable access to vaccines and medicines, national sovereignty and international cooperation.

What the Agreement Contains

  • Prevention and One Health surveillance; stronger health systems and workforce.
  • Research and development, technology transfer “on mutually agreed terms”, and a Global Supply Chain and Logistics Network.
  • Article 12 — PABS: countries share pathogen samples and genetic sequence data rapidly; in return, manufacturers that use them commit to give WHO 20% of their real-time production of vaccines, therapeutics and diagnostics during a pandemic (10% as donation, the rest at affordable prices).
  • It respects national sovereignty — WHO cannot order lockdowns or vaccine mandates.
  • It enters into force after 60 ratifications, once open for signature.

Why PABS Is Hard

  • Developing countries want legally binding benefit-sharing — the COVID-19 experience of vaccine hoarding by rich countries looms large.
  • Pharmaceutical industry and some developed countries resist mandatory terms, licensing and tech transfer.
  • Overlap with the Nagoya Protocol (2010) on access and benefit-sharing for genetic resources, and with digital sequence information (DSI) debates under the Convention on Biological Diversity.

India’s Interests

  • As the “pharmacy of the world” and the largest vaccine maker by volume, India gains from technology transfer and open supply chains (Vaccine Maitri shipped vaccines to about 100 countries).
  • As a biodiversity-rich country with a large disease burden, India wants fair returns for sharing samples — consistent with its Biological Diversity Act.
  • India supported equity-based waivers at the WTO (the TRIPS waiver proposal with South Africa, 2020).

Static Background — Global Health Governance

  • WHO: founded 1948 (7 April — World Health Day); headquarters Geneva; the World Health Assembly is its decision-making body. The United States’ withdrawal took effect in January 2026.
  • International Health Regulations (2005): legally binding; 2024 amendments introduced a “pandemic emergency” alert level above a Public Health Emergency of International Concern (PHEIC); they came into force in September 2025.
  • The Pandemic Agreement is only the second treaty negotiated under Article 19 of the WHO Constitution — the first was the Framework Convention on Tobacco Control (2003).
  • Nagoya Protocol (2010) under the CBD: access and benefit-sharing for genetic resources; India ratified it in 2012.
  • COVAX (2020): vaccine-sharing pillar of the ACT-Accelerator, co-led by Gavi, CEPI and WHO.
InstrumentYearNature
WHO Constitution1946 (in force 1948)Founding treaty
FCTC2003First treaty under Article 19
International Health Regulations2005 (amended 2024)Binding rules on outbreaks
Pandemic Agreement2025Second Article 19 treaty; PABS annex pending

Exam Angle — Prelims & Mains

  • UPSC PYQ Link: Prelims has asked on WHO-related programmes and the Nagoya Protocol (2016); Mains GS-2 on India’s role in global health governance after COVID-19.
  • Practice Mains Question (GS Paper 2, 15 marks, 250 words): Equity, not charity, should define the next pandemic response. Discuss the significance of the Pathogen Access and Benefit-Sharing system for developing countries like India.
  • Prelims Angle: Article 19 treaties, IHR amendments and the PABS 20% formula.
    • Practice Prelims MCQ 1: Consider the following statements:
      1. The WHO Pandemic Agreement was adopted by the World Health Assembly in 2025.
      2. The Framework Convention on Tobacco Control was the first treaty negotiated under Article 19 of the WHO Constitution.
      3. The Pandemic Agreement empowers WHO to impose lockdowns on member countries during a pandemic.
      Which of the statements given above are correct?
      (A) 1 and 2 only
      (B) 2 and 3 only
      (C) 1 and 3 only
      (D) 1, 2 and 3
      Show answer
      Answer: (A) 1 and 2 only — Statement 1 is CORRECT and Statement 2 is CORRECT. Statement 3 is INCORRECT — the agreement explicitly preserves national sovereignty over measures such as lockdowns and mandates.
    • Practice Prelims MCQ 2: The Nagoya Protocol deals with:
      (A) Reduction of mercury emissions
      (B) Phase-down of hydrofluorocarbons
      (C) Trade in endangered species of wild fauna and flora
      (D) Access to genetic resources and fair and equitable sharing of benefits arising from their use
      Show answer
      Answer: (D) — It is a supplementary agreement to the Convention on Biological Diversity (2010). Mercury is the Minamata Convention, wildlife trade is CITES and HFCs are the Kigali Amendment.

More International Relations from October 2026

Written by the EdiShorts editorial team from official and public sources. Check the latest position before quoting figures in the exam.